Cognitive Decline Biomarker, Tirofiban's Impact on Stroke, Peer Reviewers' Use of Artificial Intelligence

from Neurology Today in 5 · host Neurology Today

In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about a blood test that could predict cognitive decline before pathological signs, the use of tirofiban after tenecteplase for stroke, and the role of artificial intelligence in peer review.

Episode metadata supplied by the publisher feed · Published Jul 16, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Cognitive Decline Biomarker, Tirofiban's Impact on Stroke, Peer Reviewers' Use of Artificial Intelligence

0:00 4:58

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Neurology Today in 5?

This episode is 4 minutes long.

When was this Neurology Today in 5 episode published?

This episode was published on July 16, 2026.

Can I download this Neurology Today in 5 episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!